Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: The CASTOR-bifurcation registry

Catheterization and Cardiovascular Interventions

Volumn 77, Issue 4, 2011, Pages 503-509

  Sgueglia, Gregory A ^a   Burzotta, Francesco ^a   Trani, Carlo ^a   Todaro, Daniel ^a   Talarico, Giovanni Paolo ^a   Niccoli, Giampalo ^a   Porto, Italo ^a   Leone, Antonio Maria ^a   Coluccia, Valentina ^a   Mazzari, Mario Attilio ^a   Mongiardo, Rocco ^a   Schiavoni, Giovanni ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Coronary bifurcations; Drug eluting stents; Follow up; Kissing balloons; Provisional stenting

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYPHER SELECT; ENDEAVOR SPRINTER; EVEROLIMUS; UNCLASSIFIED DRUG; ZOTAROLIMUS;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BIFURCATION LESION; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RESTENOSIS; TREATMENT DURATION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; TIME FACTORS; TOR SERINE-THREONINE KINASES; TREATMENT OUTCOME;

EID: 79952222351     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22714     Document Type: Article

References (17)

1. Garot P, Lefevre T, Savage M, Louvard Y, Bamlet WR, Willerson JT, Morice MC, Holmes DR Jr. Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: A report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial. J Am Coll Cardiol 2005;46:606-612. (Pubitemid 41132685)
2. Latib A, Colombo A. Bifurcation disease: What do we know, what should we do? JACC Cardiovasc Interv 2008;1:218-226.
3. Song YB, Hahn JY, Choi SH, Choi JH, Lee SH, Jeong MH, Kim HS, Seong IW, Yang JY, Rha SW, Jang Y, Yoon JH, Tahk SJ, Seung KB, Park SJ, Gwon HC. Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: From the COBIS (Coronary Bifurcation Stenting) Registry. J Am Coll Cardiol 2010;55:1743-1750.
4. Ramcharitar S, Vaina S, Serruys PW. The next generation of drug-eluting stents: What's on the horizon? Am J Cardiovasc Drugs 2007;7:81-93.
5. Louvard Y, Thomas M, Dzavik V, Hildick-Smith D, Galassi AR, Pan M, Burzotta F, Zelizko M, Dudek D, Ludman P, Sheiban I, Lassen JF, Darremont O, Kastrati A, Ludwig J, Iakovou I, Brunel P, Lansky A, Meerkin D, Legrand V, Medina A, Lefevre T. Classification of coronary artery bifurcation lesions and treatments: Time for a consensus! Cathet Cardiovasc Interv 2008;71:175-183.
6. Burzotta F, Sgueglia GA, Trani C, Talarico GP, Coroleu SF, Giubilato S, Niccoli G, Giammarinaro M, Porto I, Leone AM, Mongiardo R, Mazzari MA, Schiavoni G, Crea F. Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: One-year clinical results of a prospective registry. J Invas Cardiol 2009;21:532-537.
7. Burzotta F, Gwon HC, Hahn JY, Romagnoli E, Choi JH, Trani C, Colombo A. Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: The T-stenting and small protrusion technique (TAP-stenting). Report of bench testing and first clinical Italian-Korean two-centre experience. Cathet Cardiovasc Interv 2007;70:75-82. (Pubitemid 47035998)
8. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-2195. (Pubitemid 350123680)
9. Ormiston JA, Webster MW, El Jack S, Ruygrok PN, Stewart JT, Scott D, Currie E, Panther MJ, Shaw B, O'Shaughnessy B. Drug-eluting stents for coronary bifurcations: Bench testing of provisional side-branch strategies. Cathet Cardiovasc Interv 2006;67:49-55. (Pubitemid 43062609)
10. Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O'Shaughnessy C, Ball MW, Turco M, Applegate RJ, Gurbel PA, Midei MG, Badre SS, Mauri L, Thompson KP, LeNarz LA, Kuntz RE. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: A randomized controlled trial. J Am Coll Cardiol 2006;48:2440-2447. (Pubitemid 44881222)
11. Beijk MA, Piek JJ. XIENCE V everolimus-eluting coronary stent system: A novel second generation drug-eluting stent. Expert Rev Med Devices 2007;4:11-21. (Pubitemid 46157678)
12. Martinet W, Verheye S, De Meyer GR. Everolimus-induced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy. Autophagy 2007;3:241-244. (Pubitemid 46752686)
13. Ge L, Airoldi F, Iakovou I, Cosgrave J, Michev I, Sangiorgi GM, Montorfano M, Chieffo A, Carlino M, Corvaja N, Colombo A. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: Importance of final kissing balloon post-dilation. J Am Coll Cardiol 2005;46:613-620. (Pubitemid 41132686)
14. Vassilev D, Gil R. Clinical verification of a theory for predicting side branch stenosis after main vessel stenting in coronary bifurcation lesions. J Interv Cardiol 2008;21:493-503.
15. Lefevre T, Louvard Y, Morice MC, Dumas P, Loubeyre C, Benslimane A, Premchand RK, Guillard N, Piechaud JF. Stenting of bifurcation lesions: Classification, treatments, and results. Cathet Cardiovasc Interv 2000;49:274-283. (Pubitemid 30133517)
16. Niemela M, Kervinen K, Erglis A, Christiansen EH, Kumsars I, Narbute I, Dombrovskis A, Gunnes P, Stavnes S, Steigen T, Trovik T, Vikman S, Niemela K, Romppanen H, Makikallio T, Hansen KN, Thayssen P, Åberge L, Hervold A, Airaksinen J, Pietila M, Frobert O, Kellerth T, Aarøe J, Ravkilde J, Helqvist S, Sjögren I, James S, Puhakka M, Mæng M, Lassen JF, Thuesen L. Nordic-Baltic Bifurcation Study III. A prospective randomized trial of side branch dilatation strategies in patients with coronary bifurcation lesions undergoing treatment with a single stent. Transcathet Cardiovasc Therapeut 2009.
17. Sangiorgi G, Romagnoli E, Biondi-Zoccai G, Margheri M, Tamburino C, Barbagallo R, Falchetti E, Vittori G, Agostoni P, Cosgrave J, Colombo A; RECIPE (Real-world Eluting-stent Comparative Italian retrosPective Evaluation) Study Investigators. Percutaneous coronary implantation of sirolimus-eluting stents in unselected patients and lesions: Clinical results and multiple outcome predictors. Am Heart J 2008;156:871-878.